Sorry, I couldn't work out how to edit my post about CSL which was not quite correct. They actually spent $1B developing the drug and market cap dropped $8 Billion. Just because RCE has $90 M market cap does not mean that drug development costs are proportionately smaller. The $1 B cost is typical of first to market cost of a new class of medications.
And "probably soon be recovered". Well I waited 3 years with no stock market movement on CSL and sold recently.
RCE Price at posting:
45.5¢ Sentiment: Buy Disclosure: Held
